DATSCAN
Drug
GE HEALTHCARE
Total Payments
$611,609
Transactions
88
Doctors
20
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1,495 | 2 | 0 |
| 2020 | $59,788 | 5 | 2 |
| 2019 | $292,315 | 6 | 1 |
| 2018 | $200,832 | 32 | 7 |
| 2017 | $57,179 | 43 | 16 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $531,110 | 11 | 86.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,763 | 21 | 5.8% |
| Consulting Fee | $22,682 | 21 | 3.7% |
| Travel and Lodging | $11,855 | 12 | 1.9% |
| Space rental or facility fees (teaching hospital only) | $8,145 | 6 | 1.3% |
| Food and Beverage | $1,554 | 16 | 0.3% |
| Grant | $500.00 | 1 | 0.1% |
Payments by Type
Research
$531,110
11 transactions
General
$80,499
77 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF URATE-ELEVATING INOSINE TREATMENT TO SLOW CLINICAL DECLINE IN EARLY PARKINSON'S DISEASE (SURE-PD3) | GE HEALTHCARE | $207,760 | 0 |
| STUDY OF URATE ELEVATION IN PARKINSON'S DISEASE, PHASE 3 (SURE-PD3) | GE HEALTHCARE | $96,390 | 0 |
| DEMENTIA WITH LEWY BODIES | GE HEALTHCARE | $67,821 | 0 |
| DEMENTIA WITH LEWY BODY CONSORTIUM | GE HEALTHCARE | $67,711 | 0 |
| DEMENTIA WITH LEWY BODIES CONSORTIUM | GE HEALTHCARE | $58,800 | 0 |
| DEMENTIAL WITH LEWY BODIES CONSORTIUM | GE HEALTHCARE | $19,600 | 0 |
| A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF URATE EVALUATING INOSINE TREATMENT TO SLOW CLINICAL DECLINE IN EARLY PARKINSONS DISEASE | GE HEALTHCARE | $7,692 | 0 |
| GE-001-011 | GE HEALTHCARE | $3,800 | 0 |
| DATSCAN IMAGING IN AGING WITH NEURODEGENERATIVE DISEASES | GE HEALTHCARE | $1,536 | 0 |
Top Doctors Receiving Payments for DATSCAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hershey, PA | $539,755 | 18 |
| , M.D., PH.D | Neurology | New Haven, CT | $26,074 | 18 |
| , MD | Neurology | Reseda, CA | $12,418 | 4 |
| , MD | Neurology | Boca Raton, FL | $9,488 | 10 |
| , MD | Neurology | Oregon City, OR | $7,050 | 6 |
| , M.D | Neurology | Alexandria, VA | $3,766 | 5 |
| , MD, PHD | Neurology | Winfield, IL | $3,570 | 7 |
| , M.D | Internal Medicine | Plantation, FL | $2,655 | 2 |
| , MD | Neurology | Tampa, FL | $2,633 | 5 |
| , M.D. PH.D | Nuclear Radiology | Hamden, CT | $2,405 | 1 |
| , MD | Neuromuscular Medicine | Austin, TX | $594.00 | 2 |
| , M.D | Neurology | Boston, MA | $187.50 | 1 |
| , M.D | Neurology | Lawrence, MA | $138.16 | 1 |
| , MD | Neurology | Washington, PA | $138.16 | 1 |
| , MD | Vascular Neurology | Jacksonville, FL | $138.16 | 1 |
| , MD | Specialist | Lawrenceville, NJ | $138.16 | 1 |
| , M.D | Neurology | Atlanta, GA | $138.16 | 1 |
| , MD | Clinical Neurophysiology | Washington, DC | $138.16 | 1 |
| , DO | Neuromuscular Medicine | Enfield, CT | $138.16 | 1 |
| , PHD | Student in an Organized Health Care Education/Training Program | Durham, NC | $37.19 | 1 |
| , MD | Physical Medicine & Rehabilitation | Kansas City, MO | $9.00 | 1 |
Ad
Manufacturing Companies
- GE HEALTHCARE $574,978
- GE Healthcare $36,630
Product Information
- Type Drug
- Total Payments $611,609
- Total Doctors 20
- Transactions 88
About DATSCAN
DATSCAN is a drug associated with $611,609 in payments to 20 healthcare providers, recorded across 88 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.
Payment data is available from 2017 to 2021. In 2021, $1,495 was paid across 2 transactions to 0 doctors.
The most common payment nature for DATSCAN is "Unspecified" ($531,110, 86.8% of total).
DATSCAN is associated with 9 research studies, including "A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF URATE-ELEVATING INOSINE TREATMENT TO SLOW CLINICAL DECLINE IN EARLY PARKINSON'S DISEASE (SURE-PD3)" ($207,760).